# Cognitive Strategies in Early Psychosis 2

> **NCT07263022** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University of Minnesota** · enrollment: 24 (estimated)

## Conditions studied

- Psychosis
- Schizophrenia Disorder
- Schizoaffective Disorder
- Major Depressive Disorder With Psychotic Features
- Bipolar Disorder With Psychotic Features
- Psychosis NOS
- Schizophreniform Disorder
- Psychotic Disorder
- Cognition

## Interventions

- **DRUG:** Modafinil
- **DRUG:** D-serine solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07263022
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-11
- **Primary completion:** 2030-04-30
- **Final completion:** 2030-04-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07263022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07263022, "Cognitive Strategies in Early Psychosis 2". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT07263022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*